Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Oct-24 4:58 PM View:  | Conn Morgan Chief Finanical Officer | Century Therapeutics, Inc. (IPSC) | 14-Oct-24 | Grant | 60,148 | -- | -- | 100% 0 to 60.15K | |
| 16-Sep-24 4:18 PM View: | Quimi Daphne Director | Century Therapeutics, Inc. (IPSC) | 12-Sep-24 | Private Purchase | 5,000 | $1.53 | $7,657.00 | 100% 0 to 5.0K | |
| 07-Aug-24 4:06 PM View: | Farid Adrienne Chief Operations Officer | Century Therapeutics, Inc. (IPSC) | 05-Aug-24 | Sale | 1,073 | $1.83 | $1,960.37 | (< 1%) 137.24K to 136.16K | |
| 07-Aug-24 4:06 PM View: | Carr Douglas SVP Finance & Operations | Century Therapeutics, Inc. (IPSC) | 05-Aug-24 | Sale | 289 | $1.83 | $528.00 | (< 1%) 334.33K to 334.04K | |
| 31-Jul-24 9:08 AM View: | Russotti Gregory See Remarks | Century Therapeutics, Inc. (IPSC) | 26-Jul-24 | Sale (Planned) | 586 | $2.50 | $1,465.00 | (< 1%) 368.29K to 367.71K | |
| 25-Jul-24 5:04 PM View: | Russotti Gregory See Remarks | Century Therapeutics, Inc. (IPSC) | 24-Jul-24 | Sale (Planned) | 1,600 | $2.52 | $4,029.44 | (< 1%) 369.89K to 368.29K | |
| 25-Jul-24 5:04 PM View: | Russotti Gregory See Remarks | Century Therapeutics, Inc. (IPSC) | 23-Jul-24 | Sale (Planned) | 200 | $2.50 | $500.00 | (< 1%) 370.09K to 369.89K | |
| 24-Jun-24 4:49 PM View: | Russotti Gregory See Remarks | Century Therapeutics, Inc. (IPSC) | 20-Jun-24 | Sale (Planned) | 5,000 | $2.84 | $14,178.50 | (1%) 375.09K to 370.09K | |
| 10-Jun-24 4:36 PM View: | Carr Douglas SVP Finance & Operations | Century Therapeutics, Inc. (IPSC) | 07-Jun-24 | Grant | 17,007 | -- | -- | 5% 317.32K to 334.33K | |
| 06-Jun-24 4:53 PM View: | Russotti Gregory See Remarks | Century Therapeutics, Inc. (IPSC) | 05-Jun-24 | Sale (Planned) | 5,000 | $3.00 | $14,989.00 | (1%) 380.09K to 375.09K | |
| 21-May-24 4:09 PM View: | Russotti Gregory See Remarks | Century Therapeutics, Inc. (IPSC) | 20-May-24 | Sale (Planned) | 5,000 | $3.00 | $14,977.50 | (1%) 385.09K to 380.09K | |
| 07-May-24 5:13 PM View: | Russotti Gregory See Remarks | Century Therapeutics, Inc. (IPSC) | 06-May-24 | Sale (Planned) | 5,000 | $3.12 | $15,619.00 | (1%) 390.09K to 385.09K | |
| 07-May-24 5:13 PM View: | Farid Adrienne Chief Operations Officer | Century Therapeutics, Inc. (IPSC) | 03-May-24 | Sale | 913 | $3.11 | $2,835.78 | (< 1%) 138.15K to 137.24K | |
| 07-May-24 5:13 PM View: | Carr Douglas SVP Finance & Operations | Century Therapeutics, Inc. (IPSC) | 03-May-24 | Sale | 257 | $3.11 | $798.24 | (< 1%) 317.58K to 317.32K | |
| 24-Apr-24 4:17 PM View: | Russotti Gregory See Remarks | Century Therapeutics, Inc. (IPSC) | 22-Apr-24 | Sale (Planned) | 5,000 | $3.10 | $15,489.50 | (1%) 395.09K to 390.09K | |
| 11-Mar-24 7:34 PM View: | Levitsky Hyam President of R&D | Century Therapeutics, Inc. (IPSC) | 07-Mar-24 | Grant | 24,000 | -- | -- | 4% 536.54K to 560.54K | |
| 18-Mar-24 5:48 PM View: | Pfeiffenberger Brent President and CEO Director | Century Therapeutics, Inc. (IPSC) | 07-Mar-24 | Grant | 17,425 | -- | -- | 1% 1.45M to 1.47M | |
| 08-Mar-24 6:29 PM View: | Farid Adrienne Chief Operations Officer | Century Therapeutics, Inc. (IPSC) | 07-Mar-24 | Planned Option Sale | 22,831 | $5.14 | $117,342.00 | (17%) 136.98K to 114.15K | |
| 11-Mar-24 7:35 PM View: | Farid Adrienne Chief Operations Officer | Century Therapeutics, Inc. (IPSC) | 07-Mar-24 | Grant | 24,000 | -- | -- | 21% 114.15K to 138.15K | |
| 08-Mar-24 6:29 PM View: | Farid Adrienne Chief Operations Officer | Century Therapeutics, Inc. (IPSC) | 07-Mar-24 | Option Exercise | 22,831 | $1.03 | $23,515.90 | 20% 114.15K to 136.98K | |
| 11-Mar-24 7:36 PM View: | Russotti Gregory See Remarks | Century Therapeutics, Inc. (IPSC) | 07-Mar-24 | Grant | 24,000 | -- | -- | 6% 371.09K to 395.09K | |
| 11-Mar-24 7:38 PM View: | Carr Douglas SVP Finance & Operations | Century Therapeutics, Inc. (IPSC) | 07-Mar-24 | Grant | 14,000 | -- | -- | 5% 303.58K to 317.58K | |
| 08-Mar-24 6:29 PM View: | Farid Adrienne Chief Operations Officer | Century Therapeutics, Inc. (IPSC) | 06-Mar-24 | Option Exercise | 30,684 | $1.03 | $31,604.50 | 27% 114.15K to 144.83K | |
| 08-Mar-24 6:29 PM View: | Farid Adrienne Chief Operations Officer | Century Therapeutics, Inc. (IPSC) | 06-Mar-24 | Planned Option Sale | 30,684 | $4.96 | $152,340.00 | (21%) 144.83K to 114.15K | |
| 21-Feb-24 4:10 PM View: | Farid Adrienne Chief Operations Officer | Century Therapeutics, Inc. (IPSC) | 16-Feb-24 | Planned Option Sale | 485 | $4.86 | $2,358.26 | (< 1%) 114.63K to 114.15K | |
| 21-Feb-24 4:10 PM View: | Farid Adrienne Chief Operations Officer | Century Therapeutics, Inc. (IPSC) | 16-Feb-24 | Option Exercise | 485 | $1.03 | $499.55 | < 1% 114.15K to 114.63K | |
| 07-Feb-24 5:21 PM View: | Farid Adrienne Chief Operations Officer | Century Therapeutics, Inc. (IPSC) | 06-Feb-24 | Sale | 1,784 | $4.49 | $8,004.81 | (2%) 115.93K to 114.15K | |
| 07-Feb-24 5:21 PM View: | Carr Douglas SVP Finance & Operations | Century Therapeutics, Inc. (IPSC) | 06-Feb-24 | Sale | 557 | $4.49 | $2,499.26 | (< 1%) 304.14K to 303.58K | |
| 07-Feb-24 5:21 PM View: | Carr Douglas SVP Finance & Operations | Century Therapeutics, Inc. (IPSC) | 05-Feb-24 | Sale | 643 | $3.84 | $2,469.76 | (< 1%) 304.78K to 304.14K | |
| 07-Feb-24 5:21 PM View: | Farid Adrienne Chief Operations Officer | Century Therapeutics, Inc. (IPSC) | 05-Feb-24 | Sale | 2,035 | $3.84 | $7,816.44 | (2%) 117.97K to 115.93K | |
| 06-Dec-23 4:07 PM View: | Pfeiffenberger Brent President and CEO Director | Century Therapeutics, Inc. (IPSC) | 04-Dec-23 | Grant | 1,453,280 | -- | -- | 100% 0 to 1.45M | |
| 03-Nov-23 4:04 PM View: | Carr Douglas SVP Finance & Operations | Century Therapeutics, Inc. (IPSC) | 01-Nov-23 | Payment of Exercise | 16,611 | $1.49 | $24,750.40 | (5%) 321.39K to 304.78K | |
| 03-Nov-23 4:04 PM View: | Diem Michael Craig Chief Financial Officer | Century Therapeutics, Inc. (IPSC) | 01-Nov-23 | Payment of Exercise | 20,763 | $1.49 | $30,936.90 | (8%) 274.3K to 253.53K | |
| 17-May-23 4:33 PM View: | Carr Douglas SVP Finance & Operations | Century Therapeutics, Inc. (IPSC) | 15-May-23 | Grant | 120,846 | -- | -- | 60% 200.54K to 321.39K | |
| 17-May-23 4:32 PM View: | Diem Michael Craig Chief Financial Officer | Century Therapeutics, Inc. (IPSC) | 15-May-23 | Grant | 151,058 | -- | -- | 123% 123.24K to 274.3K | |
| 05-Apr-23 4:27 PM View: | Borges Luis Chief Scientific Officer | Century Therapeutics, Inc. (IPSC) | 03-Apr-23 | Option Exercise | 7,452 | $1.03 | $7,675.56 | 3% 249.08K to 256.54K | |
| 23-Mar-23 7:31 PM View: | Borges Luis Chief Scientific Officer | Century Therapeutics, Inc. (IPSC) | 23-Mar-23 | Option Exercise | 220,930 | $1.03 | $227,558.00 | 505% 43.75K to 264.68K | |
| 23-Mar-23 7:31 PM View: | Borges Luis Chief Scientific Officer | Century Therapeutics, Inc. (IPSC) | 23-Mar-23 | Option Sale | 15,597 | $3.55 | $55,369.30 | (6%) 264.68K to 249.08K | |
| 23-Mar-23 7:31 PM View: | Borges Luis Chief Scientific Officer | Century Therapeutics, Inc. (IPSC) | 22-Mar-23 | Option Exercise | 65,698 | $1.03 | $67,668.90 | 150% 43.75K to 109.45K | |
| 23-Mar-23 7:31 PM View: | Borges Luis Chief Scientific Officer | Century Therapeutics, Inc. (IPSC) | 22-Mar-23 | Option Sale | 65,698 | $3.72 | $244,640.00 | (60%) 109.45K to 43.75K | |
| 23-Mar-23 7:31 PM View: | Borges Luis Chief Scientific Officer | Century Therapeutics, Inc. (IPSC) | 21-Mar-23 | Option Sale | 63,616 | $3.77 | $239,870.00 | (59%) 107.37K to 43.75K | |
| 23-Mar-23 7:31 PM View: | Borges Luis Chief Scientific Officer | Century Therapeutics, Inc. (IPSC) | 21-Mar-23 | Option Exercise | 63,616 | $1.03 | $65,524.50 | 145% 43.75K to 107.37K | |
| 06-Feb-23 6:52 PM View: | Carr Douglas VP Finance & Operations | Century Therapeutics, Inc. (IPSC) | 02-Feb-23 | Grant | 15,000 | -- | -- | 8% 185.54K to 200.54K | |
| 06-Feb-23 6:49 PM View: | Farid Adrienne Chief Operations Officer | Century Therapeutics, Inc. (IPSC) | 02-Feb-23 | Grant | 43,750 | -- | -- | 59% 74.22K to 117.97K | |
| 06-Feb-23 6:49 PM View: | Diem Michael Craig Chief Business Officer | Century Therapeutics, Inc. (IPSC) | 02-Feb-23 | Grant | 43,750 | -- | -- | 55% 79.49K to 123.24K | |
| 06-Feb-23 6:50 PM View: | Borges Luis Chief Scientific Officer | Century Therapeutics, Inc. (IPSC) | 02-Feb-23 | Grant | 43,750 | -- | -- | 100% 0 to 43.75K | |
| 11-Aug-22 4:55 PM View: | Versant Venture Capital Vi,... 10% Owner | Century Therapeutics, Inc. (IPSC) | 09-Aug-22 | Disposition (other) | 364,800 | -- | -- | (3%) 13.08M to 12.72M | |
| 11-Aug-22 4:55 PM View: | Versant Venture Capital Vi,... 10% Owner | Century Therapeutics, Inc. (IPSC) | 09-Aug-22 | Sale (Planned) | 550,000 | $13.03 | $7,166,610.00 | (4%) 12.72M to 12.17M | |
| 02-Feb-22 4:31 PM View: | Versant Venture Capital Vi,... 10% Owner | Century Therapeutics, Inc. (IPSC) | 31-Jan-22 | Disposition (other) | 178,996 | -- | -- | (1%) 13.26M to 13.08M | |
| 28-Dec-21 4:46 PM View: | Versant Venture Capital Vi,... 10% Owner | Century Therapeutics, Inc. (IPSC) | 23-Dec-21 | Disposition (other) | 371,004 | -- | -- | (3%) 13.63M to 13.26M |
